Related Experiment Video

Updated: May 23, 2026

Prion Safety Laboratory Swipe Test
06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

Sporadic Creutzfeldt-Jakob disease: a description of two cases

Kavita Das1, Rebecca Davis, Brett Dutoit

  • 1Department of Old Age Psychiatry, Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, Surrey, UK. kavita.das@btinternet.com

International Psychogeriatrics
|March 23, 2012
PubMed

Insights

Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare, rapidly progressive dementia affecting the central nervous system. Coordinated care and information sharing are crucial for managing this devastating neurodegenerative illness.

Area of Science:

  • Neurology
  • Neurodegenerative Diseases
  • Prion Diseases

Background:

  • Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common human prion disease.
  • It affects approximately 50 individuals annually in the UK.
  • sCJD is characterized by rapidly progressive dementia and neurological dysfunction.

Observation:

  • sCJD presents with diverse symptoms indicative of central nervous system damage.
  • The disease poses significant diagnostic and management challenges.
  • Palliative care is a critical component of sCJD patient management.

Findings:

  • Effective management of sCJD requires seamless coordination between healthcare services.
  • Clear communication and information exchange are vital for optimal patient care.
  • Psychiatry services play a frequent role in assessing and managing sCJD patients.

Implications:

  • Improved inter-service collaboration can enhance care delivery for sCJD patients.
  • Standardized diagnostic and management protocols may alleviate challenges.
  • Further research into sCJD pathogenesis and treatment is warranted.

More Related Videos

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material09:50

Real-time Quaking-induced Conversion Assay for Detection of CWD Prions in Fecal Material

Published on: September 29, 2017

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain11:29

Isolation of Soluble and Insoluble PrP Oligomers in the Normal Human Brain

Published on: October 3, 2012

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...